"AIDS-like" Genetically Engineered Virus In Pfizer Labs

A genetically engineered "AIDS-like" virus? Passing mention is given to such a virus in the following story which is mostly about the legal shenanigans involved in a lawsuit won by a research scientist who blew the whistle on her former employer, Pfizer Pharmaceuticals. The lawsuit is about alleged 'safety' lapses. The fact that there is an admitted "AIDS-like" virus that is genetically engineered is ignored as though of no importance whatsoever.

Actually that is the story!

Let Pfizer tell us more about this genetically engineered "AIDS-like" virus!

Is this where the AIDS virus came from?

Who engineered it and why?

Where did you get it and are there any more like this one?

What do you need it for and what do you intend to do with it?

Pfizer Ordered To Pay Up Over'AIDS-Like' Virus Infections

RawStory4-9-10
In what is being hailed as a major victory for workers in the biotech and nanotech fields, a former scientist with pharmaceutical firm Pfizer has been awarded $1.37 million for being fired after raising the alarm over researchers being infected with a genetically engineered "AIDS-like" virus.
Becky McClain, a molecular biologist from Deep River, Connecticut, filed a lawsuit against Pfizer in 2007, claiming she had been wrongly terminated for complaining about faulty safety equipment that allowed a "dangerous lentivirus" to infect her and some of her colleagues.
The Hartford Courant describes the virus as "similar to the one that can lead to acquired immune deficiency syndrome, or AIDS." Health experts testified that the virus has affected the way McClain's body processes potassium, which they say causes McClain to suffer complete paralysis as often as a dozen times per month, the Courant reports.
McClain's lawsuit (PDF) asserted that Pfizer had interfered with her right to free speech, and that she should have been protected from retaliation by whistleblower legislation.
Pfizer challenged her assertion, claiming McClain only started complaining about safety problems once her employment was terminated, the Associated Press reports. Pfizer also claimed to have investigated McClain's claims about safety violations and found them to be untrue, according to the New London Day.
On Thursday, a jury in a US District Court in Connecticut disagreed with Pfizer, granting McClain the $1.37 million, as well as punitive damages, meaning the total amount could be much greater.
The WorkersCompensation.com Web site says the ruling is being "considered the first successful employee claim in the biotech and nanotech industry."
Workers' rights advocates are pointing to the McClain lawsuit as "evidence that risks caused by cutting-edge genetic manipulation have outstripped more slowly evolving government regulation of laboratories," reports the Courant.
McClain's lawsuit says she was exposed to the experimental virus repeatedly between 2002 and 2004, and when she lodged complaints about it, her supervisor said he would "falsify her future performance reviews and he told her they would be negative, and he threatened her in an aggressive fashion following the plaintiff's repeated complaints regarding safety. He forcibly backed the plaintiff into a wall during one encounter."
'TOO BIG TO NAIL'
A report at CNN about a separate legal matter involving Pfizer states that the Department of Justice considered Pfizer to be "too big to nail" in an investigation of the company's illegal marketing of the painkiller drug Bextra.
CNN reports that, if Pfizer had been prosecuted over the drug, the company would have been excluded from doing business with Medicaid and Medicare. But because federal officials considered the company too big to be exempted from working with the government health programs, a dummy corporation -- Pharmacia & Upjohn Inc. -- was set up, and that dummy corporation then pleaded guilty to the crime.
"P&UCI sold no drugs and had no real employees, and its creation was simply a figleaf to allow a Pfizer entity to take the rap without harming Pfizer itself," explains Jim Edwards at the Bnet business blog.
Pfizer is the world's largest drugmaker, with annual revenue around $44 billion.
http://www.blacklistednews.com/news-8100-0-6-6--.html

AIDS Cure Suppression

HIV/AIDS cure gets little attention?

When I first saw this article I thought it was going to be about me and the work we have been doing since 1991 with the first AIDS cure - low dose oral alpha interferon. It turns out that it is about a much more complicated and expensive procedure involving a transplant of mutated stem cells. Specifically stem cells with the CC-5 Delta 32 mutation which occurs in many people of European ancestry. This mutation dates back to the 14th Century and those who at that time survived the bubonic plague or Black Death that wiped out 30% of Europe's population.

Why didn't the several documented cures from HIV/AIDS that have occurred under the care of this physician capture any (positive) attention? Or the Kenyan doctors, notably Dr Davy Koech (pictured above) who were the original pioneers in the use of low dose alpha interferon..?

When they called an international press conference to announce the cure for HIV/AIDS, the world press did attend, but, then, did not report any of the results. That's why Dr Barbara Justice and I went to Kenya and learned all about the use of low dose alpha interferon and brought it back to the US. Only the Final Call and a few other black newspapers published anything about it. Even when I announced it at the Million Man March, with the cured individual standing by my side, that still was not enough to blow the lid off the suppression of the truth.

The question then and the question now is WHY?

Well, in the first instance, the Kenyan discovery of alpha interferon, unbeknownst to them, actually uncovered a strategic secret of the US defense establishment. Interferon alpha was the antidote to their viral biological weapons! Can't let that cat out of the bag. Interferon would have neutralized the bio weapons arsenal. Can't have that, so suppress any news about this AIDS cure.

What about CCR-5 Delta 32 mutation? Well, same thing really. It reveals that those scientists who 'invented' the AIDS virus knew about the protective effect of CCR-5. They designed it to specifically target and ill effect non-white people who are not of European descent, who do not have the CCR-5 in their gene pool!

In other words, HIV is an ethnic weapon.

The CCR-5 mutation proves it! Therefore, ignore it, don't report it. People will begin to put two and two together. Therefore, the policy is suppression. If these cures for incurable AIDS are to be known, we have to do that independently.

The discovery of a cure for a genocidal epidemic is not good news for the genocidalists.

HIV/AIDS cure getting little publicity

Dr. Awadhesh Gupta said medical ‘politics’ could be reason

By Bob Morgan

FOLEY, Ala. — A Foley physician said what appears to be the first case of HIV/AIDS cure in the world is getting little mention in the media.
Dr. Awadhesh K. Gupta, medical director at Foley Walk-In Med Care, said he first heard of the medical breakthrough in April when he attended the Annual Conference of the American College of Physicians in Internal Medicine in Philadelphia.It’s a conference Gupta tries to attend every year.“This is the most prestigious organization of physicians in Internal Medicine and is responsible for certifying post graduate training in Internal Medicine. It is also one of the oldest,” he said.According to Gupta, who has been practicing medicine in the South Baldwin area since 1997, the cure was first reported in early 2008 by a group of physicians from Germany at the annual conference on “Retroviruses and Opportunistic Infections” in Boston. The New England Journal of Medicine, one of the most prestigious medical journals in the world, finally published the report in its Feb. 12, 2009, issue, Gupta said.So why has the news of the first case of HIV/AIDS cure received so little attention where the public is concerned?“I can’t be sure as to why so little publicity,” Gupta said recently.“My guess is that most scientific researchers are somewhat stunned that a clinician — not a research scientist — has been able to come up with the cure. Most of the big research money and big name American institutions are somewhat embarrassed to acknowledge that the very first case of HIV cure is not coming from their institutions.” The cure, instead, is coming from Charity University Hospital in Berlin, Germany, and the doctor is Gero Huetter, who works in the Department of Hematology, Oncology and Transfusion Medicine at the same hospital.Asked about the reaction of attendees at the medical conference in Philadelphia as regarded the news of an HIV/AIDS cure, Gupta said, “Unfortunately, because of the hectic schedule, I did not try to engage too many physicians. However, the doctor presenting this information seemed extremely excited about it.”AN AMERICANWORKING IN BERLINAs Gupta explains the case and cure in question, a 40-year-old American working in Berlin had been HIV-positive for 10 years. The patient’s HIV infection had been under control for four years with “conventional HAART treatment regimen” (Highly Active Anti-Retroviral Therapy).When the patient developed leukemia, however, a bone marrow transplant of stem cells was done using standard protocol, which Gupta said includes radiation therapy and chemotherapy prior to the transplant.“Remember, once you stop HIV drugs, the HIV viral count rises very rapidly, usually within a few days to a week,” Gupta said.According to Gupta, Huetter, the German physician treating the American, deliberately chose a stem cell donor who had a gene mutation known as “CCR-5 Delta- 32,” rather than using the best matched donor.Gupta said Huetter remembered research first observed in 1996 - research Gupta said is well known in the scientific community. That research found that certain gay men in the San Francisco area remained uninfected with HIV in spite of engaging in risky sexual activities. As it was later discovered, those men had the CCR-5 Delta-32 gene mutation.As it turned out, the patient’s stem cell transplant was a success, Gupta said, even though the patient had to have a second stem cell transplant (from the same donor) when his leukemia relapsed.“This patient has been off all his HIV drugs for two years now,” Gupta said. “He continues to show no detectable signs of HIV in all the known places HIV is detected — no signs of HIV in his blood, bone marrow, lymph nodes, intestines or brain.” Also, the patient’s T-cell count remains normal.Thus, according to Gupta, within the limits of scientists’ ability to detect HIV, it appears this patient’s HIV has been “eradicated.”CCR-5 DELTA-32The gene mutation CCR-5 Delta-32 is found mostly in white European populations, especially northern Europeans and Scandanavians, according to Gupta, who is on the staff of South Baldwin Regional Medical Center and served as chief of medicine in 2008.“Those who have this gene mutation from both parents are completely resistant to most common forms of HIV infection. You can get tested for it if you wish,” he said.“It is believed that this genetic mutation may have happened during long periods of small pox, plague and other pandemics that devastated European populations.”While the “American living in Berlin” case is in Gupta’s words the “first case of confirmed cure of HIV in the world,” he cites a 1989 case that is similar. Dr. John Rossi, currently at City of Hope Cancer Center in Durate, Calif., had a 41-year-old patient with AIDS and lymphoma. The patient underwent radiation and drug therapy in removing his bone marrow and receiving new cells from a donor.Whether the donor had the CCR-5 Delta-32 gene mutation or not is not known, Gupta said, but when the patient died of his cancer at age 47 autopsy tests from eight organs and the tumor revealed no HIV.“I have no doubts that present day high tech stem cell transplantation from CCR-5 Delta-32 donors can cure HIV,” Gupta said, noting, at the same time, that the procedure is expensive at present and has significant risks of complications and a high mortality related to the procedure itself.